Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: Influence of margin status and systemic therapy on local recurrence

Journal of Clinical Oncology

Volumn 18, Issue 8, 2000, Pages 1668-1675

  Park, Catherine C ^a   Mitsumori, Michihide ^a   Nixon, Asa ^a   Recht, Abram ^a   Connolly, James ^a   Gelman, Rebecca ^a   Silver, Barbara ^a   Hetelekidis, Stella ^a   Abner, Anthony ^a   Harris, Jay R ^a   Schnitt, Stuart J ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 17744407628     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.8.1668     Document Type: Article

References (23)

1. Winchester DP, Cox JD: Standards for diagnosis and management of invasive breast carcinoma. CA Cancer J Clin 48:83-107, 1998
2. Holland R, Connolly J, Gelman R, et al: The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 8:113-118, 1990
3. Holland R, Veling S, Mravunac M, et al: Histologic multifocality of Tis, T1-2 breast carcinomas: Implications for clinical trials of breast-conserving surgery. Cancer 56:979-990, 1985
4. Gage I, Schnitt SJ, Nixon AJ, et al: Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer 78:1921-1928, 1996
5. Schnitt SJ, Abner A, Gelman R, et al: The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer 74:1746-1751, 1994
6. Schnitt SJ, Connolly JL, Khettry U, et al: Pathologic findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy. Cancer 59:675-681, 1987
7. Fisher B, Redmond C, Poisson R, et al: Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 320:822-828, 1989
8. Dalberg K, Mattson A, Rutqvist LE, et al: Breast conserving surgery for invasive breast cancer: Risk factors for ipsilateral breast tumor recurrences. Breast Cancer Res Treat 43:73-86, 1997
9. Anscher MS, Jones P, Prosnitz LR, et al: Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy. Ann Surg 218:22-28, 1993
10. Clarke DH, Le MG, Sarrazin D, et al: Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: Experience at the Institut Gustav-Roussy. Int J Radiat Oncol Biol Phys 11:137-145, 1985
11. Peterson ME, Schultz DJ, Reynolds C, et al: Outcomes in breast cancer patients relative to margin status after treatment with breast-conserving surgery and radiation therapy: The University of Pennsylvania experience. Int J Radiat Oncol Biol Phys 43:1029-1035, 1999
12. Freedman G, Fowble B, Hanlon A, et al: Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy, Int J Radiat Oncol Biol Phys 44:1005-1015, 1999
13. Smitt MC, Nowels KW, Zdeblick MJ, et al: The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer 76:259-267, 1995
14. Wazer DE, Schmidt-Ullrich RK, Ruthazer R, et al: Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumor bed. Int J Radiat Oncol Biol Phys 40:545-552, 1998
15. German R, Gelber R, Henderson IC, et al: Improved methodology for analyzing local and distant recurrence. J Clin Oncol 8:548-555, 1990
16. Fisher B, Dignam J, Mamounas EP, et al: Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: Eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil. J Clin Oncol 14:1982-1992, 1996
17. Fisher B, Constantino J, Redmond C, et al: A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 320:479-484, 1989
18. Fisher B, Constantino J, Wickerham L, et al: Adjuvant therapy for node-negative breast cancer: An update of the NSABP findings. Proc Am Soc Clin Oncol 12:79a, 1993 (abstr 79)
19. Dalberg K, Johansson H, Johansson U, et al: A randomized trial of long term adjuvant tamoxifen plus postoperative radiation therapy versus radiation therapy alone for patients with early stage breast carcinoma treated with breast-conserving therapy: Stockholm Breast Cancer Study Group. Cancer 82:2204-2211, 1998
20. Recht A, Come S, Henderson IC, et al: The sequencing of chemotherapy and radiation therapy after conservative surgery for early stage breast cancer. N Engl J Med 334:1356-1361, 1996
21. Hartsell WF, Recine DC, Griem KL, et al: Delaying the initiation of intact breast irradiation for patients with lymph node positive breast cancer increases the risk of local recurrence. Cancer 76:2497-2503, 1995
22. Schnitt SJ, Connolly JL: Processing and evaluation of breast excision specimens: A clinically oriented approach. Am J Clin Pathol 98:125-137, 1992
23. Carter D: Margins of "lumpectomy " for breast cancer. Hum Pathol 17:330-332, 1986